back to Meetings page
- IMMPACT-X Slide Presentations
- 1. Scope of the problem of prescription opioid abuse: public health perspective
- Richard A. Denisco, MD
- 2. Deterrence of prescription opioid abuse: FDA perspective
- Bob A. Rappaport, MD
- 3. Clinical studies of abuse deterrent opioid analgesics: definitions, current approaches, and critical issues
- Nathaniel P. Katz, MD
- 4. Current status of experimental human abuse liability studies: methods, outcomes, and predictive validity for real-world abuse
- Sandra D. Comer, PhD
- 5. Limitations of experimental human abuse liability studies and prospects for improvement
- James P, Zacny, PhD
- 6. Retrospective analyses of abuse-related outcomes in clinical trials of analgesic drugs and their interpretation
- Michael Klein, PhD
- 7. How can abuse-related outcomes be prospectively evaluated in clinical trials of analgesic drugs?
- Deborah B. Leiderman, MD
- 8. Randomized clinical trials of abuse: limitations and prospects for improvement
- Edgar H. Adams, ScD
- 9. Observational and claims data studies of abuse-related outcomes: limitations and prospects for improvement
- Nabarun Dasgupta, MPH
- 10. The use of poison center data to assess the relative abuse rates of prescription opioids
- Richard Dart, MD, PhD
- 11. The use of addiction center data to assess abuse of prescription opioids
- John Brownstein, PhD